- Home
- COLL vs PLAY Comparison
COLL vs PLAY Comparison
Compare COLL & PLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- PLAY
- Stock Information
- Founded
- COLL 2002
- PLAY 1982
- Country
- COLL United States
- PLAY United States
- Employees
- COLL N/A
- PLAY N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- PLAY Restaurants
- Sector
- COLL Health Care
- PLAY Consumer Discretionary
- Exchange
- COLL Nasdaq
- PLAY Nasdaq
- Market Cap
- COLL 910.2M
- PLAY 804.3M
- IPO Year
- COLL 2015
- PLAY 1995
- Fundamental
- Price
- COLL $26.79
- PLAY $19.51
- Analyst Decision
- COLL Strong Buy
- PLAY Buy
- Analyst Count
- COLL 5
- PLAY 6
- Target Price
- COLL $43.60
- PLAY $27.00
- AVG Volume (30 Days)
- COLL 393.2K
- PLAY 1.6M
- Earning Date
- COLL 05-08-2025
- PLAY 04-07-2025
- Dividend Yield
- COLL N/A
- PLAY N/A
- EPS Growth
- COLL 43.56
- PLAY N/A
- EPS
- COLL 1.86
- PLAY 1.46
- Revenue
- COLL $631,449,000.00
- PLAY $2,132,700,000.00
- Revenue This Year
- COLL $19.96
- PLAY $6.58
- Revenue Next Year
- COLL $3.93
- PLAY $4.58
- P/E Ratio
- COLL $14.31
- PLAY $13.34
- Revenue Growth
- COLL 11.41
- PLAY N/A
- 52 Week Low
- COLL $23.23
- PLAY $15.08
- 52 Week High
- COLL $42.29
- PLAY $57.10
- Technical
- Relative Strength Index (RSI)
- COLL 43.80
- PLAY 53.42
- Support Level
- COLL $25.87
- PLAY $18.85
- Resistance Level
- COLL $27.95
- PLAY $20.84
- Average True Range (ATR)
- COLL 1.50
- PLAY 1.56
- MACD
- COLL 0.05
- PLAY 0.38
- Stochastic Oscillator
- COLL 69.33
- PLAY 76.91
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About PLAY Dave & Buster's Entertainment Inc.
Dave & Buster's Entertainment Inc owns and operates nearly a hundred entertainment and dining establishments in the United States where customers can eat, drink, play games, and watch televised sports. Each store offers a full menu of entries and appetizers, a complete selection of alcoholic and non-alcoholic beverages, and an extensive assortment of entertainment attractions centered around playing games and watching live sports and other televised events. It derives maximum revenue from Entertainment.